• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Mayo Clinical Reviews


<























































I’m a KAM. Just riding it out for a few more years. The money is great and the little to no work is also great. It’s overpaid part time job with nice benefits. You’ve got to be okay with playing the game. Makes me feel a little dirty at the end of each day. There is ZERO access here. Yep, I’m in the upper Midwest.